‘Adaptive licensing’ or ‘adaptive pathways’: deregulation under the guise of earlier access
Position paper by Health Action International, ISDB, the Medicines in Europe Forum, the Mario Negri Institute for Pharmacological Research, the Nordic Cochrane and Wemos
Rapport
- 15/10/2015